Cécile Simondi

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

François‐Clément Bidard, William Jacot, Nicolas Kiavué et al. · JAMA Oncology · 2020 · 168 citations · Full text

Abstract GS3-07: Clinical utility of circulating tumor cell count as a tool to chose between first line hormone therapy and chemotherapy for ER+ HER2- metastatic breast cancer: Results of the phase III STIC CTC trial

F-C Bidard, William Jacot, Sylvain Dureau et al. · Cancer Research · 2019 · 32 citations

Breast Oncology, Patient Selection, Cancer Management +18

Anxiety and specific distress in women at intermediate and high risk of breast cancer before and after surveillance by magnetic resonance imaging and mammography versus standard mammography

Anne Brédart, Jean‐Luc Kop, Mouhamadou Fall et al. · Psycho-Oncology · 2011 · 22 citations

Perception of care and experience of examination in women at risk of breast cancer undergoing intensive surveillance by standard imaging with or without MRI

Anne Brédart, Jean‐Luc Kop, Mouhamadou Fall et al. · Patient Education and Counseling · 2011 · 14 citations

Nursing, Imaging Anatomy, Primary Care +13

Laparoscopic hysterectomy after concurrent radiochemotherapy in locally advanced cervical cancer compared to laparotomy: A multi institutional prospective pilot study of cost, surgical outcome and quality of life

Sandrine Baffert, S. Alran, Virginie Fourchotte et al. · European Journal of Surgical Oncology · 2015 · 10 citations · Full text

Advanced Cervical Cancer, Laparoscopy, Surgical Oncology +11